Solara Active Pharma Sciences Publishes Newspaper Ads for Rights Issue Final Call

2 min read     Updated on 25 Mar 2026, 09:16 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Solara Active Pharma Sciences has published newspaper advertisements in Business Standard and Pratahkal informing shareholders about the second and final call of ₹112.50 per share on partly paid-up equity shares. The company set April 2, 2026, as the record date and announced trading suspension from April 1, 2026, while also providing a re-lodgement window for previously rejected physical share transfers.

powered bylight_fuzz_icon
35468913

*this image is generated using AI for illustrative purposes only.

Solara Active Pharma Sciences Limited has successfully concluded its Rights Issue Committee meeting and published newspaper advertisements informing shareholders about the second and final call of ₹112.50 per share on partly paid-up equity shares. The pharmaceutical company has set April 2, 2026, as the record date for determining eligible shareholders who must pay the call money.

Committee Meeting Outcomes and Advertisement Publication

Following the Rights Issue Committee meeting held on March 24, 2026, the company published advertisements in Business Standard and Pratahkal newspapers on March 25, 2026. The advertisements inform shareholders about the second and final call and the record date for determining eligible shareholders. These advertisements are also available on the company's website at https://solara.co.in/investor-relations/newspaper-publications .

Final Call Details: Information
Call Amount: ₹112.50 per share
Face Value Component: ₹3.00 per share
Securities Premium: ₹109.50 per share
Call Type: Second and Final Call
Record Date: April 2, 2026
Advertisement Date: March 25, 2026
Publications: Business Standard, Pratahkal

Trading Suspension and Shareholder Obligations

The company has officially notified that trading in partly paid-up equity shares (ISIN: IN9624201022) will be suspended on stock exchanges with effect from April 1, 2026. Shareholders holding partly paid-up equity shares issued under the rights offering must pay the final call amount of ₹112.50 per share to convert these into fully paid-up equity shares. Call notices will be dispatched to eligible shareholders for payment of the call amount.

Share Transfer Re-lodgement Window

The company has also announced a re-lodgement window for physical share transfer requests that were previously rejected. Shareholders can re-lodge transfer requests from February 5, 2024, to February 4, 2027, for transfers that were rejected before April 1, 2019, or those lodged before April 1, 2019, but rejected due to document deficiencies. The re-lodged securities will be transferred only in demat mode once all documents are verified by the Registrar and Transfer Agent, Cameo Corporate Services Limited.

Regulatory Compliance and Documentation

Company Secretary and Compliance Officer Pooja Jaya Kumar has signed all official communications to stock exchanges, ensuring proper regulatory disclosure under SEBI Listing Regulations. The company maintains full compliance with Regulation 30 and 42 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, throughout the rights issue process. The comprehensive documentation includes the original Letter of Offer dated May 9, 2024, and all subsequent regulatory filings related to the rights issue completion.

Historical Stock Returns for Solara Active Pharma Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.70%+4.26%+3.01%-21.35%-7.09%-63.21%

How will Solara Active Pharma Sciences utilize the additional capital raised from this final call to expand its pharmaceutical operations or R&D capabilities?

What potential impact could non-payment by some shareholders have on Solara's capital structure and the forfeiture of partly paid-up shares?

Will the completion of this rights issue position Solara for potential acquisitions or strategic partnerships in the pharmaceutical sector?

Solara Active Pharma Sciences
View Company Insights
View All News
like17
dislike

Rallis India Opens Special Window for Physical Share Transfer Re-lodgement

2 min read     Updated on 25 Mar 2026, 08:59 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Rallis India Limited has opened a special window until February 5, 2026 for shareholders to re-lodge physical share transfer requests that were previously rejected or unprocessed due to documentation issues. The facility follows SEBI guidelines and requires submission of corrected documents to the company's registrar MUFG Intime India Private Limited, with all re-lodged shares to be issued in demat mode under one-year lock-in period.

powered bylight_fuzz_icon
35996660

*this image is generated using AI for illustrative purposes only.

Rallis India Limited , a Tata Enterprise, has announced the opening of a special window for re-lodgement of transfer requests of physical shares through newspaper advertisements published on March 25, 2026. The pharmaceutical company has established this facility following SEBI guidelines to assist shareholders with previously rejected or unprocessed share transfer requests.

Special Window for Physical Share Transfer

In accordance with SEBI Circular No. HO/MIRSD/MIRSD_RTAMB/P/CIR/2020/166 dated September 07, 2020, the company has opened a special window until February 5, 2026 to facilitate re-lodgement of transfer of physical shares. This window specifically addresses shares that were lodged prior to April 1, 2019 for transfer and were subsequently rejected, returned, or not attended to due to deficiency in documents, process, or formalities.

Window Details: Information
Opening Period: Until February 5, 2026
Eligible Shares: Physical shares lodged before April 1, 2019
Issue Mode: Demat mode only
Lock-in Period: One year from transfer registration date

Transfer Process and Requirements

The shares that are re-lodged for transfer shall be issued only in demat mode and shall be under lock-in for a period of one year from the date of registration of transfer. Eligible shareholders are requested to submit the necessary original transfer documents along with corrected or missing details and other requisite documents to the company's Registrar and Transfer Agent.

Transfer Agent Details: Information
Name: MUFG Intime India Private Limited
Former Name: Link Intime India Private Limited
Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083
Deadline: February 5, 2026
Query Portal: https://web.mufg.intime.com/helpdesk/Service_Request.html

Exclusions and Limitations

Cases involving disputes between transferor and transferee shall not be considered in this special window and may be settled by transferor and transferee through Court/NCLT process. Additionally, shares which have been transferred to Investor Education and Protection Fund shall not be considered under this window for processing.

Regulatory Compliance and Publication

The announcement was made pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The newspaper advertisement was published in multiple newspapers on March 25, 2026, including Business Standard (English), The Free Press Journal (English), and Navshakti (Marathi).

Publication Details: Information
Business Standard: All editions
The Free Press Journal: Mumbai edition
Navshakti: Mumbai edition
Company Website: www.rallis.com

The communication was signed by Sariga P Gokul, Company Secretary & Compliance Officer, ensuring proper authorization and regulatory compliance. The information is also available on the company's website for shareholder reference.

Historical Stock Returns for Solara Active Pharma Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.70%+4.26%+3.01%-21.35%-7.09%-63.21%

How might the one-year lock-in period for transferred shares impact Rallis India's stock liquidity and trading volumes?

Will other Tata Group companies follow similar special windows for physical share transfers, potentially setting an industry precedent?

What operational challenges might MUFG Intime India face in processing potentially large volumes of re-lodged transfer requests before the February 2026 deadline?

Solara Active Pharma Sciences
View Company Insights
View All News
like15
dislike

More News on Solara Active Pharma Sciences

1 Year Returns:-7.09%